1. Switzerland Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
SES Solar Inc.

SES Solar Inc.

SESI
SES Solar Inc.US flagOther OTC
0.00
USD
- -
- -
7,308.00Market Cap
SES Solar Inc.
SESI
(Other OTC)

Recent

price

0.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2004
2005
2006
2007
2008
2009
TTM
FRC
- -
0.05
- -
0.02
- -
0.02
0.08
Revenue per Share
- -
-0.02
-0.04
-0.03
-0.01
-0.02
0.01
Basic EPS, GAAP
- -
-0.02
-0.06
-0.12
-0.17
-0.07
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
-0.01
-0.04
-0.07
-0.07
-0.06
-0.07
-0.06
Book Value per Share
- -
-0.02
0.19
0.07
0.04
0.03
0.04
Tangible Book Value per Share
19
24
30
56
73
73
73
Basic Weighted Avg Shares
- -
1
- -
1
- -
1
6
Sales/Revenue/Turnover
-18,205.68
-42.08
-972.67
-140.42
-5,894.16
-94.27
3.21
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
-1
-1
-2
- -
-1
- -
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
-18,310.95
-45.93
-958.81
-113.33
-1,419.84
-90.94
8.25
Profit Margin (%)
- -
- -
6
-6
-9
-16
7
Working Capital
- -
1
1
- -
2
1
- -
LT Debt
- -
-1
6
4
3
2
3
Total Equity
- -
- -
- -
- -
- -
- -
1.18
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
6.83
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Mar'10
Jun'10
Sep'10
ST Debt
14
14
9
LT Borrowings
1
1
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
73
73
73
Market Capitalization
7
5
3

Working Capital

FRC

•

in mil. unless spec.
Mar'10
Jun'10
Sep'10
Total Current Assets
1
1
19
Cash, Cash Equivalents & STI
1
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
18
17
12
Payables & Accruals
2
3
3
ST Debt
14
14
9
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
23.87%
-40.46%
Free Cash Flow
- -
242.68%
-55.97%
Net Income, GAAP
- -
147.31%
156.12%
Sales/Revenue/Turnover
- -
47,246.38%
3,898.65%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2008
- -
- -
- -
- -
- -
2009
1
- -
- -
- -
1
2010
- -
1
4
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2008
- -
0.01
-0.01
- -
-0.01
2009
-0.01
- -
- -
- -
-0.02
2010
-0.01
- -
0.02
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2008
- -
- -
- -
- -
- -
2009
- -
- -
- -
- -
- -
2010
- -
- -
- -
- -
- -
Similar Companies
Hypera S.A. (HYPMY)
Teva Pharmaceutical Industries Limited (TEVA.TA)
1933 Industries Inc. (TGIF.CN)
Taro Pharmaceutical Industries Ltd. (TARO)
Piramal Enterprises Limited (PEL.NS)
Orexo AB (publ) (ORX.ST)
Business
SES Solar Inc. operates within the photovoltaic energy sector in Switzerland, providing a range of innovative solar solutions. The company develops and supplies diverse solar power products, including specialized solar tiles designed for standard application on urban or rural properties, suitable for both flat and sloped rooftops. Additionally, it offers custom, architecturally integrated panels constructed from glass/glass tedlar, ideal for building envelopes such as glazing, transparent openings in commercial and residential structures, and veranda coverings. The firm also delivers complete project management services, overseeing initiatives from the initial design phase through to successful implementation. Furthermore, SES Solar Inc. furnishes ongoing monitoring, upkeep, and operational support to ensure system longevity and performance. Established in 2001, the company maintains its principal office in Plan-les-Ouates, Switzerland. Since November 23, 2010, SES Solar Inc. has functioned as an entity under Flannel Management Sàrl.